These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30707502)

  • 41. [Neoplastic mastocytosis evolving from a poor prognosis acute myeloid leukemia].
    Chen-Liang TH; Jerez A; Florensa L; Ortuño FJ
    Med Clin (Barc); 2015 Jun; 144(12):571-2. PubMed ID: 25249393
    [No Abstract]   [Full Text] [Related]  

  • 42. Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL).
    Carella AM; Pungolino E; Piatti G; Giordano D; Cerri R; Risso M; Nati S
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():50-1. PubMed ID: 2713562
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index.
    Kawasaki Y; Kimura SI; Nakano H; Mashima K; Shirato Y; Kawaguchi SI; Toda Y; Ochi SI; Nagayama T; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Sato K; Oh I; Fujiwara SI; Ohmine K; Kako S; Muroi K; Kanda Y
    Int J Hematol; 2019 Apr; 109(4):470-476. PubMed ID: 30684252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk.
    Schoen MW; Woelich SK; Braun JT; Reddy DV; Fesler MJ; Petruska PJ; Freter CE; Lionberger JM
    Leuk Res; 2018 May; 68():72-78. PubMed ID: 29574395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of cytarabine and idarubicin in a newly diagnosed AML patient with a severe wound.
    Bozoglan H; Ergene U; Yoleri L
    Transfus Apher Sci; 2011 Aug; 45(1):17-20. PubMed ID: 21727029
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.
    Berman E; Raymond V; Gee T; Kempin SJ; Gulati S; Andreeff M; Kolitz J; Gabrilove J; Heller G; Young CW
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808
    [No Abstract]   [Full Text] [Related]  

  • 47. [Acute myeloid leukemia with poor prognosis: treatment with oral 4-demethoxydaunorubicin (idarubicin) and low-dose cytarabine via subcutaneous route].
    Helg C; Chapuis B; Grob JP; Pugin P
    Schweiz Med Wochenschr; 1990 Apr; 120(15):548-52. PubMed ID: 2336558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.
    Ferrara F; Izzo T; Criscuolo C; Riccardi C; Celentano M; Mele G
    Am J Hematol; 2010 Sep; 85(9):687-90. PubMed ID: 20652967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
    Wiernik PH; Case DC; Periman PO; Arlin ZA; Weitberg AB; Ritch PS; Todd MB
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):25-9. PubMed ID: 2928807
    [No Abstract]   [Full Text] [Related]  

  • 50. Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience.
    Romani C; Di Tucci AA; Dessalvi P; Pettinau M; Emanuele A
    Am J Hematol; 2010 Mar; 85(3):219. PubMed ID: 20063278
    [No Abstract]   [Full Text] [Related]  

  • 51. Donor cell leukemia developing after hematopoietic stem cell transplantation for multiple myeloma.
    Havelange V; Antoine-Poirel H; Saussoy P; Van Den Neste E; Ferrant A
    Acta Clin Belg; 2006; 61(2):82-6. PubMed ID: 16792340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.
    Cho JH; Hur M; Moon HW; Yun YM; Ko YS; Kim WS; Lee MH
    Hum Pathol; 2012 Apr; 43(4):605-9. PubMed ID: 22036054
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of decreased-dose idarubicin for elderly patients with acute myeloid leukemia.
    Kobayashi T; Ichikawa M; Nannya Y; Kurokawa M
    Jpn J Clin Oncol; 2013 Oct; 43(10):1047-51. PubMed ID: 23956441
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with acute myelogenous leukemia or myelodysplastic syndrome.
    Estey EH; Kantarjian H; Keating M
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):1-5. PubMed ID: 8290966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Idarubicin in combination with intermediate-dose cytarabine in the treatment of refractory or relapsed acute leukemias.
    Carella AM; Pungolino E; Piatti G; Gaozza E; Nati S; Spriano M; Giordano D; D'Amico T; Damasio E
    Eur J Haematol; 1989 Oct; 43(4):309-13. PubMed ID: 2583257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Escalated anthracycline dose in adult AML.
    Balakrishnan VS
    Lancet Oncol; 2017 May; 18(5):e253. PubMed ID: 28416149
    [No Abstract]   [Full Text] [Related]  

  • 57. Central line-associated bacteremia caused by drug-resistant Staphylococcus caprae after chemotherapy for acute myelogenous leukemia.
    Kato J; Mori T; Sugita K; Murata M; Ono Y; Yamane A; Shimizu T; Okamoto S
    Int J Hematol; 2010 Jun; 91(5):912-3. PubMed ID: 20390386
    [No Abstract]   [Full Text] [Related]  

  • 58. Wernicke's Encephalopathy in an Acute Myeloid Leukemia Patient: A Case Study.
    Maden M; Pamuk G; Çelik Y; Ünlü E
    Turk J Haematol; 2016 Mar; 33(1):78-9. PubMed ID: 27020725
    [No Abstract]   [Full Text] [Related]  

  • 59. Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21).
    Ong SY; Ho LP; Yeo PM; Ng HJ; Ang AL
    Int J Hematol; 2017 Aug; 106(2):149-150. PubMed ID: 28390036
    [No Abstract]   [Full Text] [Related]  

  • 60. Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabine.
    Ruutu T; Hänninen A; Järventie G; Koistinen P; Koivunen E; Kätkä K; Nousiainen T; Oksanen K; Pelliniemi TT; Remes K; Timonen T; Volin L; Elonen E
    Leuk Res; 1997 Feb; 21(2):133-8. PubMed ID: 9112430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.